Table 3.
Correlation of Age, Number of Injections, Baseline CMT and BCVA with Final CMT and Final BCVA
| Variables | Group 1 | Group 2 | Group 1 | Group 2 | ||||
|---|---|---|---|---|---|---|---|---|
| Final BCVA | Final CMT | |||||||
| R | P value | R | P value | R | P value | R | P value | |
| Age | 0.36 | 0.052 | −0.1 | 0.6 | 0.1 | 0.4 | 0.2 | 0.3 |
| Number of injections | 0.6 | 0.001* | 0.4 | 0.03* | 0.4 | 0.02* | 0.2 | 0.3 |
| Baseline CMT | 0.4 | 0.01* | 0.3 | 0.09 | −0.01 | 0.9 | −0.1 | 0.5 |
| Baseline BCVA | 0.5 | 0.007* | 0.4 | 0.01* | 0.2 | 0.3 | −0.05 | 0.8 |
Note: *Significant.
Abbreviations: CMT, central macular thickness; BCVA, best corrected visual acuity; R, correlation coefficient.